COVID-19对髋部骨折后死亡率的影响:一项来自英格兰的人群队列研究
该研究基于英格兰国家髋部骨折数据库2019年2月1日至2020年10月31日的102,900例髋部骨折患者,链接多种数据源分析COVID-19感染对90天死亡率的影响。结果显示,就诊时感染COVID-19者90天死亡风险翻倍(HR 2.09),就诊后8至30天感染者风险更高(HR 2.51)。2020年1月1日至6月30日期间,髋部骨折后90天内超额死亡1,273例,超额死亡率为23%。
要点
- 就诊时感染COVID-19的髋部骨折患者90天死亡风险翻倍(HR 2.09)。
- 就诊后8至30天感染COVID-19者死亡风险更高(HR 2.51)。
- 2020年上半年髋部骨折后90天内超额死亡率达23%,多数死亡发生在30天内。
核心结论
- COVID-19感染使早期髋部骨折死亡率增加一倍以上。
- 在初次就诊后8至30天之间感染的患者死亡风险更高,提示该期间可能存在针对性干预以改善生存的机会。
研究设计与样本
- 研究为队列研究,纳入英格兰国家髋部骨折数据库2019年2月1日至2020年10月31日记录的髋部骨折患者。
- 数据链接至医院 episode 统计、国家统计局死亡数据和英格兰公共卫生署SARS-CoV-2检测结果。
- 采用多变量Cox回归分析90天死亡率的决定因素,并使用准泊松模型量化COVID-19归因超额死亡。
- 共分析102,900例髋部骨折,其中42,630例发生于大流行期间。
主要发现
- 就诊时感染COVID-19的患者(n=1,120)90天死亡风险翻倍,HR 2.09(95%CI 1.89至2.31)。
- 就诊后8至30天感染COVID-19的患者(n=1,644)死亡风险更高,HR 2.51(95%CI 2.31至2.73)。
- 在COVID-19阳性患者中,营养不良(HR 1.45,95%CI 1.19至1.77)和非手术治疗(HR 2.94,95%CI 2.18至3.95)是仅有的可改变死亡风险因素。
- 髋部骨折前两周以上COVID-19检测阳性的患者初始生存优于骨折前后感染COVID-19者,但生存迅速下降,至365天时髋部骨折合并COVID-19感染与50%死亡率相关。
- 2020年1月1日至6月30日期间,髋部骨折后90天内发生1,273例超额死亡(99.7%CI 1,077至1,465),超额死亡率为23%(99.7%CI 20%至26%),多数死亡发生在30天内。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Hip fracture commonly affects the frailest patients, of whom many are care-dependent, with a disproportionate risk of contracting COVID-19. We examined the impact of COVID-19 infection on hip fracture mortality in England. METHODS: We conducted a cohort study of patients with hip fracture recorded in the National Hip Fracture Database between 1 February 2019 and 31 October 2020 in England. Data were linked to Hospital Episode Statistics to quantify patient characteristics and comorbidities, Office for National Statistics mortality data, and Public Health England's SARS-CoV-2 testing results. Multivariable Cox regression examined determinants of 90-day mortality. Excess mortality attributable to COVID-19 was quantified using Quasi-Poisson models. RESULTS: Analysis of 102,900 hip fractures (42,630 occurring during the pandemic) revealed that among those with COVID-19 infection at presentation (n = 1,120) there was a doubling of 90-day mortality; hazard ratio (HR) 2.09 (95% confidence interval (CI) 1.89 to 2.31), while the HR for infections arising between eight and 30 days after presentation (n = 1,644) the figure was greater at 2.51 (95% CI 2.31 to 2.73). Malnutrition (1.45 (95% CI 1.19 to 1.77)) and nonoperative treatment (2.94 (95% CI 2.18 to 3.95)) were the only modifiable risk factors for death in COVID-19-positive patients. Patients who had tested positive for COVID-19 more than two weeks prior to hip fracture initially had better survival compared to those who contracted COVID-19 around the time of their hip fracture; however, survival rapidly declined and by 365 days the combination of hip fracture and COVID-19 infection was associated with a 50% mortality rate. Between 1 January and 30 June 2020, 1,273 (99.7% CI 1,077 to 1,465) excess deaths occurred within 90 days of hip fracture, representing an excess mortality of 23% (99.7% CI 20% to 26%), with most deaths occurring within 30 days. CONCLUSION: COVID-19 infection more than doubles the rate of early hip fracture mortality. Those contracting infection between 8 and 30 days after initial presentation are at even higher mortality risk, signalling the potential for targeted interventions during this period to improve survival.Cite this article: Bone Joint J 2022;104-B(10):1156-1167.
引用
- Holleyman RJ, Khan SK, Charlett A, et al. The impact of COVID-19 on mortality after hip fracture : a population cohort study from England. Bone Joint J. 2022. PMID: 36177635. doi:10.1302/0301-620X.104B10.BJJ-2022-0082.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。